RT Journal Article
SR Electronic
T1 Supraspinal control of motoneurons after paralysis enabled by spinal cord stimulation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.29.23298779
DO 10.1101/2023.11.29.23298779
A1 Balaguer, Josep-Maria
A1 Prat-Ortega, Genis
A1 Verma, Nikhil
A1 Yadav, Prakarsh
A1 Sorensen, Erynn
A1 de Freitas, Roberto
A1 Ensel, Scott
A1 Borda, Luigi
A1 Donadio, Serena
A1 Liang, Lucy
A1 Ho, Jonathan
A1 Damiani, Arianna
A1 Grigsby, Erinn
A1 Fields, Daryl P.
A1 Gonzalez-Martinez, Jorge A.
A1 Gerszten, Peter C.
A1 Fisher, Lee E.
A1 Weber, Douglas J.
A1 Pirondini, Elvira
A1 Capogrosso, Marco
YR 2023
UL http://medrxiv.org/content/early/2023/12/01/2023.11.29.23298779.abstract
AB Spinal cord stimulation (SCS) restores motor control after spinal cord injury (SCI) and stroke. This evidence led to the hypothesis that SCS facilitates residual supraspinal inputs to spinal motoneurons. Instead, here we show that SCS does not facilitate residual supraspinal inputs but directly triggers motoneurons action potentials. However, supraspinal inputs can shape SCS-mediated activity, mimicking volitional control of motoneuron firing. Specifically, by combining simulations, intraspinal electrophysiology in monkeys and single motor unit recordings in humans with motor paralysis, we found that residual supraspinal inputs transform subthreshold SCS-induced excitatory postsynaptic potentials into suprathreshold events. We then demonstrated that only a restricted set of stimulation parameters enables volitional control of motoneuron firing and that lesion severity further restricts the set of effective parameters. Our results explain the facilitation of voluntary motor control during SCS while predicting the limitations of this neurotechnology in cases of severe loss of supraspinal axons.Competing Interest StatementMC and DW hold patents in relation to spinal cord stimulation. MC and DW are the founders of Reach Neuro, a company developing spinal cord stimulation technologies for stroke. All other authors declare they have no competing interests.Funding StatementThis study was supported by start-up funds to MC from the Department of Neurosurgery, University of Pittsburgh, start-up funds to EP from the Department of Physical Medicine and Rehabilitation, University of Pittsburgh, and NIH grant number UG3NS123135 to MC and DW.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board (IRB) of the University of Pittsburgh gave ethical approval for this work (protocols STUDY19090210 and STUDY22020031).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.